全文获取类型
收费全文 | 29721篇 |
免费 | 1713篇 |
国内免费 | 299篇 |
专业分类
耳鼻咽喉 | 202篇 |
儿科学 | 755篇 |
妇产科学 | 657篇 |
基础医学 | 1376篇 |
口腔科学 | 180篇 |
临床医学 | 6696篇 |
内科学 | 3844篇 |
皮肤病学 | 230篇 |
神经病学 | 1379篇 |
特种医学 | 744篇 |
外科学 | 3081篇 |
综合类 | 3586篇 |
预防医学 | 4697篇 |
眼科学 | 79篇 |
药学 | 3337篇 |
44篇 | |
中国医学 | 442篇 |
肿瘤学 | 404篇 |
出版年
2023年 | 595篇 |
2022年 | 791篇 |
2021年 | 1294篇 |
2020年 | 1437篇 |
2019年 | 1250篇 |
2018年 | 1220篇 |
2017年 | 1110篇 |
2016年 | 959篇 |
2015年 | 1016篇 |
2014年 | 2219篇 |
2013年 | 2422篇 |
2012年 | 2026篇 |
2011年 | 2122篇 |
2010年 | 1647篇 |
2009年 | 1443篇 |
2008年 | 1359篇 |
2007年 | 1282篇 |
2006年 | 1142篇 |
2005年 | 885篇 |
2004年 | 752篇 |
2003年 | 628篇 |
2002年 | 450篇 |
2001年 | 389篇 |
2000年 | 357篇 |
1999年 | 310篇 |
1998年 | 268篇 |
1997年 | 246篇 |
1996年 | 226篇 |
1995年 | 278篇 |
1994年 | 172篇 |
1993年 | 140篇 |
1992年 | 147篇 |
1991年 | 146篇 |
1990年 | 127篇 |
1989年 | 95篇 |
1988年 | 108篇 |
1987年 | 83篇 |
1986年 | 80篇 |
1985年 | 110篇 |
1984年 | 101篇 |
1983年 | 59篇 |
1982年 | 54篇 |
1981年 | 35篇 |
1980年 | 38篇 |
1979年 | 26篇 |
1978年 | 24篇 |
1977年 | 19篇 |
1976年 | 7篇 |
1975年 | 13篇 |
1973年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Carlos Casas-Arozamena Cristian Pablo Moiola Ana Vilar Marta Bouso Juan Cueva Silvia Cabrera Victoria Sampayo Efigenia Arias Alicia Abalo Ángel García Ramón Manuel Lago-Lestón Sara Oltra Eva Díaz Juan Ruiz-Bañobre Rafael López-López Gema Moreno-Bueno Antonio Gil-Moreno Eva Colás Miguel Abal Laura Muinelo-Romay 《International journal of cancer. Journal international du cancer》2023,152(10):2206-2217
The analysis of mismatch repair proteins in solid tissue is the standard of care (SoC) for the microsatellite instability (MSI) characterization in endometrial cancer (EC). Uterine aspirates (UAs) or circulating-DNA (cfDNA) samples capture the intratumor heterogeneity and provide a more comprehensive and dynamic molecular diagnosis. Thus, MSI analysis by droplet-digital PCR (ddPCR) in UAs and cfDNA can provide a reliable tool to characterize and follow-up the disease. The UAs, paraffin-embedded tumor tissue (FFPE) and longitudinal plasma samples from a cohort of 90 EC patients were analyzed using ddPCR panel and compared to the SoC. A high concordance (96.67%) was obtained between the analysis of MSI markers in UAs and the SoC. Three discordant cases were validated as unstable by ddPCR on FFPE samples. Besides, a good overall concordance (70.27%) was obtained when comparing the performance of the ddPCR assay on UAs and cfDNA in high-risk tumors. Importantly, our results also evidenced the value of MSI analysis to monitor the disease evolution. MSI evaluation in minimally invasive samples shows great accuracy and sensitivity and provides a valuable tool for the molecular characterization and follow-up of endometrial tumors, opening new opportunities for personalized management of EC. 相似文献
2.
3.
4.
李鸣贺华马宗奎孙辉毛冰范晶王汉祥刘艳王荣黄兵程惠玲陈蕾唐蔚武宇沈波 《中国卫生质量管理》2022,(10):108-111
探索重大突发公共卫生事件中以亚定点医院为代表的医疗管理模式。从上海新国际博览中心W1亚定点医院的实际运行情况出发,对其医疗供需、收治标准、运行效果、存在问题等逐一分析,结合本医疗队的经验,提出新的工作模式和管理思路。亚定点医院为普通型和有基础疾病的新冠病毒阳性感染者提供及时有效的救治,缓解了定点医院的运行压力,但也暴露出人员配置、信息化支撑、院感防控等方面的问题。采取“两级缓冲、双向转诊”的工作模式和“三个快、三个准、三个稳、三个全”的管理方案,可为患者提供及时、有效、适宜的医疗服务,缓解定点医院运行压力。 相似文献
5.
6.
目的 探讨急诊介入栓塞治疗对于急性重度静脉曲张上消化道出血(ASVUGIB)患者的临床价值。方法 收集直接或补救介入治疗的48例ASVUGIB患者数据。按急诊介入原因分为直接介入治疗组(40例)及补救性介入治疗组(8例), 对经DSA明确造影剂外溢的直接出血征象患者行经皮经肝/经脾门静脉造影+曲张静脉栓塞术+ 经颈静脉肝内门体分流术(TIPS);对经DSA未发现明确出血征象的患者行经皮经肝/经脾门静脉造影+曲张静脉栓塞术, 术中视门静脉压力情况行经TIPS术;对于存在门-体异常分流道患者, 行球囊阻断逆行经静脉闭塞术(BRTO)+ TIPS, 治疗后随访6个月, 观察患者的临床预后。结果 直接介入治疗组患者的出血病变血管检出率为78%, 治疗有效率为78%;7 d、30 d、3个月、6个月内再出血率分别为23%、45%、45%、45%;7 d内、30 d内、3个月内、6个月内病死率分别为15%、28%、28%、28%。补救性介入治疗组患者DSA出血病变血管检出率为6/8, 治疗有效率为6/8;7 d、30 d、3个月、6个月内再出血率分别为1/8、4/8、4/8、4/8;7 d内、30 d内、3个月内、6个月内病死率分别为1/8、3/8、3/8、3/8。介入治疗后患者转氨酶、白蛋白、总胆红素和凝血功能指标均比治疗前好转(P均< 0.05), Child-Pugh评分及终末期肝病模型评分均低于治疗前(P均< 0.05)。结论 ASVUGIB是临床常见的危急症, 早发现、早干预、早治疗可改善患者预后, 介入栓塞治疗可作为存在胃镜治疗相对禁忌或胃镜治疗失败的ASVUGIB患者的治疗选择。 相似文献
7.
《Journal of emergency nursing》2022,48(5):525-537
IntroductionEmergency nurses experience occupational stressors resulting from exposures to critical clinical events. The purpose of this study was to identify the critical clinical events for emergency nurses serving 3 patient populations (general, adult, pediatric) and whether the resilience of these nurses differed by the patient population served.MethodsThis study used a cross-sectional survey design. A total of 48 emergency nurses were recruited from 3 trauma hospital-based emergency departments (general, adult, pediatric). Clinical Events Questionnaire, Connor-Davidson Resilience scale, and an investigator-developed demographic questionnaire were used to collect data from respondents.ResultsAll respondents were female (n = 48, 100%), and most were White (n = 46, 96%). The average age of participants was 39.6 years, the average number of years as a registered nurse was 12.7 years, and the average number of years as an emergency nurse was 8.8 years. Clinical events considered most critical were providing care to a sexually abused child, experiencing the death of a coworker, and lack of responsiveness by a colleague during a serious situation. The least stress-provoking event was incidents with excessive media coverage. Nurses were less affected by the critical events they experienced more frequently at work. Nurses in the 3 trauma settings had high level of resilience, with no statistically significant differences between groups.DiscussionThe occupational stress from exposure to significant clinical events varied with the patient population served by emergency nurses. It is important that interventions be adopted to alleviate the effect of work-related stressors and promote the psychological health of emergency nurses. 相似文献
8.
《Nutrition, metabolism, and cardiovascular diseases : NMCD》2022,32(1):21-31
AimThis review aims to summarize and discuss some of the most relevant clinical trials in epidemiology, diagnostics, and treatment of hypertension published in 2020 and 2021.Data synthesisThe trials included in this review are related to hypertension onset age and risk for future cardiovascular disease, reliability of different blood pressure monitoring methods, role of exercise-induced hypertension, treatment of hypertension in patients with SARS-CoV-2 infection, management of hypertension high-risk patient groups, e.g., in the elderly (≥80 years) and patients with atrial fibrillation, and the interplay between nutrition and hypertension, as well as recent insights into renal denervation for treatment of hypertension.ConclusionsHypertension onset age, nighttime blood pressure levels and a riser pattern are relevant for the prognosis of future cardiovascular diseases. The risk of coronary heart disease appears to increase linearly with increasing exercise systolic blood pressure. Renin-angiotensin system blockers are not associated with an increased risk for a severe course of COVID-19. In elderly patients, a risk-benefit assessment of intensified blood pressure control should be individually evaluated. A J-shaped association between cardiovascular disease and achieved blood pressure could also be demonstrated in patients with atrial fibrillation on anticoagulation. Salt restriction and lifestyle modification remain effective options in treating hypertensive patients at low cardiovascular risk. Sodium glucose co-transporter 2 inhibitors and Glucagon-like peptide-1 receptor agonists show BP-lowering effects. Renal denervation should be considered as an additional or alternative treatment option in selected patients with uncontrolled hypertension. 相似文献
9.
目的 了解某国家级死因监测点居民死亡漏报情况,评价死因监测信息系统报告的完整性和准确性。 方法 某国家级死因监测点居民死亡信息来源于泸县3个抽样点。采用随机整群抽样的方法,在泸县抽取3个镇(抽样点)共42个村/社,分别从派出所、社事办、妇幼、村(居委会)等渠道收集抽样点2018—2020年全部人口死亡信息,与“人口死因监测信息管理系统”死亡报告数据进行比较,计算漏报率。对“人口死因监测信息管理系统”中抽样点居民死亡报告卡进行审核,评估死因诊断的可靠性和编码质量。 结果 泸县人群总死亡漏报率为9.38%;2018—2020年,漏报率逐渐下降,分别为18.31%、7.53%、2.16%,年度变化百分比为-11.9%,变化趋势差异有统计学意义(t=-5.175,P<0.001),抽样点死因诊断可靠性和准确性较高,可靠诊断单位占比81.81%,可靠诊断依据占比75.67%,根本死因编码错误率为0.21%。 结论 泸县死因监测数据质量较好,但仍需进一步降低漏报率,提高死因监测数据的完整性和诊断的可靠性。 相似文献
10.
《Drug discovery today》2022,27(1):280-291
Positron emission tomography (PET) is an extensively used nuclear functional imaging technique, especially for central nervous system (CNS) and oncological disorders. Currently, drug development is a lengthy and costly pursuit. Imaging with PET radiotracers could be an effective way to hasten drug discovery and advancement, because it facilitates the monitoring of key facets, such as receptor occupancy quantification, drug biodistribution, pharmacokinetic (PK) analyses, validation of target engagement, treatment monitoring, and measurement of neurotransmitter concentrations. These parameters demand careful analyses for the robust appraisal of newly formulated drugs during preclinical and clinical trials. In this review, we discuss the usage of PET imaging in radiopharmaceutical development; drug development approaches with PET imaging; and PET developments in oncological and cardiac drug discovery. 相似文献